Stay updated with breaking news from Vaskar saha. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
When Katie Currie was diagnosed with leukaemia as a toddler, the lives of her family changed overnight. Here, they share how doctors, nurses and an experimental drug brought hope – and then eventual recovery
Non-profit Bureau of Investigative Journalism recently issued a report showing that at least a dozen brands of chemotherapy drug asparaginase have been found to be substandard but are still on [...]
Acute lymphoblastic leukaemia is the most common kind of childhood cancer but the drugs containing asparaginase are of poor quality, leaving 70 000 children at risk
Research at The University of Manchester has made a significant impact nationally and internationally on improving the outcome for children with acute lymphoblastic leukaemia (ALL). Survival rates of children with ALL in the west have risen from 60% to 90%, though in countries with limited resources ALL continues to be a fatal disease. Globally, the survival rate for children with ALL is around 40%. Professor Vaskar Saha has helped to increase survival rates by 10% in the UK and in India. By linking five major paediatric centres, he has created a national hub of cancer centres which work together to agree standards of care based on the principles of the NHS. They have implemented agreed, uniform standards of care and treatment across all of the treatment centres and formed the Indian Childhood Collaborative Leukaemia (ICiCLe) group.